Community-acquired methicillin-resistant Staphylococcus aureus: time to address the problem.
Malebranche
David J
DJ
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002353:Carrier State; D017714:Community-Acquired Infections / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology*; D003428:Cross Infection / Q000453:epidemiology / Q000382:microbiology; D006801:Humans; D016106:Methicillin Resistance; D009666:Nose / Q000382:microbiology; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology*; D013211:Staphylococcus aureus / Q000187:drug effects* / Q000235:genetics; D014481:United States / Q000453:epidemiology
D000900:Anti-Bacterial Agents